benzinga biotech small cap conference: immutep limited (asx:imm, nasdaq:immp) march 24, 2021
Published 3 years ago • 243 plays • Length 23:47
Download video MP4
Download video MP3
Similar videos
-
28:03
benzinga biotech small cap conference: coming together to address unmet medical needs - mar 24, 2021
-
12:28
immutep (asx:imm, nasdaq:immp) ceo marc voigt provides an update on clinical trials
-
7:13
from the helm: immutep's (asx:imm, nasdaq:immp) executive director & ceo marc voigt
-
21:21
biotech unlocked - immutep asx:imm
-
5:19
cramer: this biotech stock could be worth over $100 billion on an fda approval
-
17:24
the quest for small-molecule cancer immunotherapeutics
-
7:09
relativity-047: relatlimab (rela) plus nivolumab (nivo) versus nivo in first-line advanced melanoma
-
4:32
immutep limited (asx:imm; nasdaq:immp) ceo and executive director marc voigt provides company update
-
10:01
immutep limited (asx:imm, nasdaq:immp) encouraging results for immutep's cancer therapies
-
6:25
immutep (asx:imm, nasdaq:immp) discusses a transformative year for lag-3 therapies
-
14:13
immutep limited - asx small & mid cap conference
-
7:43
immutep (asx:imm; nasdaq: immp) company update on start of 2021
-
5:58
ausbiz interview with ceo marc voigt, march 17, 2021, immutep limited (asx: imm; nasdaq: immp)
-
46:43
immutep limited (asx:imm, nasdaq:immp) - webcast presentation for cohort b of tacti-003 trial
-
6:42
immutep (asx:imm, nasdaq:immp) lag-3 validated in bristol myers squibb trial
-
27:17
immutep limited (asx:imm, nasdaq:immp) - fireside chat with immutep limited
-
7:13
from the helm: immutep's (asx:imm) executive director & ceo marc voigt
-
4:40
immutep (asx:imm) announces encouraging trial data for lung cancer therapy
-
52:08
immutep (asx:imm, nasdaq:immp) global webcast presentation at sitc 2022
-
4:44
immutep (asx:imm, nasdaq:immp) - innovative cancer therapies
-
6:59
immutep (asx:imm; nasdaq: immp) global leader in development of lag 3 gene immuno-therapies
Clip.africa.com - Privacy-policy